Sutter Francis P, Wertan MaryAnn C, Spragan Danielle, Yamashita Yoshiyuki, Sicouri Serge
Department of Cardiac Surgery Research, Lankenau Institute for Medical Research, Main Line Health, Wynnewood, PA, USA.
Department of Cardiac Surgery, Lankenau Heart Institute, Lankenau Medical Center, Main Line Health, Wynnewood, PA, USA.
Ann Cardiothorac Surg. 2024 Jul 31;13(4):346-353. doi: 10.21037/acs-2024-rcabg-0033. Epub 2024 Jul 29.
The first robotic cardiac operation was performed more than two decades ago. This paper describes the distinct steps and components necessary for teaching robotic-assisted minimally invasive direct coronary artery bypass (R-MIDCAB). It also provides a general overview of the surgical robotic setup and ways to troubleshoot potential complications. The focus of robotic training is not only on the surgeon but includes an entire dedicated cardiac team and administrative institutional support. This team approach ensures that R-MIDCAB can be performed safely and reproducibly. Meticulous planning, incremental learning, and teamwork are the main factors leading to program success and optimal patient outcomes. Robotic-assisted internal mammary artery (IMA) harvesting and coronary revascularization via a small, anterior mini-thoracotomy has provided an alternative to sternotomy in selected patients with coronary artery disease (CAD). Benefits include less postoperative atrial fibrillation, fewer blood transfusion, less time in the operating room (OR), less ventilatory support, fewer strokes, decreased intensive care unit stay and shortened postoperative length of stay all of which manifests as a decrease in institutional resource utilization. Recent data show that R-MIDCAB and hybrid coronary revascularization provides good long-term outcomes. In addition to patient satisfaction, there is an additional overall cost benefit to R-MIDCAB over traditional sternotomy coronary artery bypass grafting (CABG), secondary to decreased hospital length of stay. Robotically harvesting the IMA, operating on a beating heart, and performing anastomoses through a small incision all require advanced training and incremental learning. Increased experience generally leads to shortened surgical times and fewer complications.
首例机器人心脏手术是在二十多年前进行的。本文描述了教授机器人辅助微创直接冠状动脉旁路移植术(R-MIDCAB)所需的不同步骤和组成部分。它还概述了手术机器人的设置以及解决潜在并发症的方法。机器人手术培训的重点不仅在于外科医生,还包括整个专门的心脏团队和行政机构的支持。这种团队协作方式确保了R-MIDCAB能够安全且可重复地进行。精心规划、渐进式学习和团队合作是实现项目成功和患者最佳治疗效果的主要因素。机器人辅助下的胸廓内动脉(IMA)获取以及通过小切口前外侧开胸进行冠状动脉血运重建,为部分冠状动脉疾病(CAD)患者提供了一种替代胸骨切开术的方法。其益处包括术后房颤发生率降低、输血次数减少、手术室(OR)停留时间缩短、通气支持减少、中风减少、重症监护病房停留时间缩短以及术后住院时间缩短,所有这些都表现为机构资源利用率的降低。近期数据表明,R-MIDCAB和杂交冠状动脉血运重建可带来良好的长期治疗效果。除了患者满意度外,与传统胸骨切开冠状动脉旁路移植术(CABG)相比,R-MIDCAB还具有额外的总体成本效益,这得益于住院时间的缩短。机器人获取IMA、在跳动的心脏上进行手术以及通过小切口进行吻合都需要高级培训和渐进式学习。经验的增加通常会导致手术时间缩短和并发症减少。